- Conditions
- Myopia
- Interventions
- 0.01% concentration atropine drops
- Drug
- Lead sponsor
- Jeffrey J. Walline, OD PhD
- Other
- Eligibility
- 21 Years to 30 Years
- Enrollment
- 31 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
Source: ClinicalTrials.gov public record
Updated Dec 1, 2022 · Synced May 22, 2026, 2:47 AM EDT